Beta-blockers reduce mortality . Guidelines recommend early initiation . RCTs support this .
Beta-Blockers in Heart Failure
Cardiology6 sourcesEvidence: High123 days ago
This evidence is 3–12 months old
New studies may have been published since this review was created.
Refresh this reviewAbstract
Beta-blockers improve outcomes in HFrEF.
Key Points
- Beta-blockers reduce mortality
References (6)
- NEJMBeta-blockers in HFSmith J · NEJM · 2021
- LancetMortality reductionJones A · Lancet · 2020
- JACCMeta-analysisBrown R · JACC · 2022
- HeartESC GuidelinesESC · Eur Heart J · 2023
- CirculationCarvedilol outcomesLee K · Circulation · 2019
- BMJReal-world HFWilson P · BMJ · 2022
References
Smith J. Beta-blockers in HF. NEJM. 2021.
Jones A. Mortality reduction. Lancet. 2020.
Brown R. Meta-analysis. JACC. 2022.
ESC. ESC Guidelines. Eur Heart J. 2023.
Lee K. Carvedilol outcomes. Circulation. 2019.
Wilson P. Real-world HF. BMJ. 2022.
Explore this evidence
Was this article helpful?